Dozens of major hospitals may ignore an FDA decision allowing use of plasma from recovered COVID-19 patients in order to focus on a clinical trial.
Dozens of hospitals poised to defy FDA on plasma therapy for COVID-19 patients https://t.co/64I2ig9ORF